Inactive Instrument

Press Releases IP GROUP Swiss Exchange

Equities

IPO

GB00B128J450

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Ultraleap Launches Hyperion: the next generation tracking software platform	May. 10	PU
IP : C-Capture Launches Innovative Carbon Capture Trial for Cement Industry	May. 10	PU
IP : Bramble Energy achieves milestone in hydrogen fuel cell production, advancing UK’s electrified automotive future	May. 09	PU
IP : Hysata announces $111m USD Series B investment round	May. 09	PU
Finguerra-DuCharme And Garber Write About Key Fashion Trademark Cases	May. 03	AQ
IP : Genomics plc and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design	Apr. 30	PU
IP : Notice of the 2024 Annual General Meeting	Apr. 24	PU
IP : First Light Fusion - First Light Founder moves into new science-focused role with Acting CEO appointed	Apr. 22	PU
IP : Kynos Therapeutics announces positive top line results from the first-in-human Phase I study of its KMO inhibitor, KNS366, demonstrating safety, tolerability and target engagement	Apr. 22	PU
IP : First Light Fusion solves major engineering challenge in the design of an Inertial Confinement Fusion pilot power plant	Apr. 03	PU
IP : Tissue Regenix Group plc - Final results for the year ended 31 December 2023	Mar. 19	PU
Mission Therapeutics raises GBP25.2 million to progress clinical candidates in the area of mitophagy	Mar. 15	AQ
IP : Mission Therapeutics raises £25.2 million to progress clinical candidates in the area of mitophagy	Mar. 14	PU
IP : Moa Techology - Moa to develop next-gen bioherbicides in new 10-year commercial partnership with Croda	Mar. 13	PU
IP : Oxford Nanopore Technologies and SeqOne partner to support interpretation of nanopore sequencing in clinical use	Mar. 12	PU
IP : Quantum Dice And HSBC Collaborate On The Use Of QRNGs To Enhance Financial Monte Carlo Simulations	Mar. 05	PU
IP : Oxford Nanopore Technologies plc - Directorate Change	Mar. 01	PU
IP : Oxford Nanopore Technologies plc - Appoints Two Non-Executive Directors	Dec. 19	PU
IP : Ultraleap and Prophesee enter into a strategic partnership to provide industry-first hand tracking on event sensors for AR devices	Dec. 19	PU
IP : Mission Therapeutics announces US FDA approval to initiate Phase II clinical trial of its lead asset MTX652 in Acute Kidney Injury	Dec. 14	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IP GROUP Swiss Exchange

Equities

IPO

GB00B128J450

Press Releases

Filters